Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda

Published on October 14, 2024

Sabin has delivered investigational Marburg vaccines to Rwanda to combat a deadly outbreak. The initial batch of 700 doses, followed by 1,000 more, is being used to vaccinate frontline healthcare workers in an open-label study. The outbreak, declared on September 27, has caused 46 infections and 12 deaths. Sabin's vaccine, based on the cAd3 platform, has shown promise in ongoing trials, with no safety concerns reported. Sabin's rapid response was supported by global partnerships, including Rwanda's Biomedical Centre and BARDA. To read more and access updates, click the link below!

Access the News Release!

Other news

Unicef Polio Vaccines Protect Children in Gaza Strip

October 14, 2024
In Gaza, UNICEF is working to protect children from polio by providing vaccines amid challenging conditions. In collaboration with partners, UNICEF has successfully delivered over 800,000 doses of polio vaccine to ensure children remain safe from the disease. This effort is part of a broader campaign to strengthen immunization systems and safeguard children’s health, despite ongoing conflicts and

WHO: Better Use of Vaccines Could Reduce Antibiotic Use by 2.5 Billion

October 15, 2024
A recent WHO report highlights that better use of vaccines could reduce global antibiotic use by 2.5 billion doses annually, addressing antimicrobial resistance (AMR). Vaccines prevent infections and reduce the misuse of antibiotics, particularly for diseases like pneumonia, typhoid, and malaria. Expanding vaccine coverage and developing new vaccines, such as those for tuberculosis and Klebsiella